Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence H Schwartz

Showing results (1-10 of 278) with videos related to

Pageof 28
Sort By:
The Oncologist|October 1, 2009
Contemporary imaging in sarcomaJonathan Landa, Lawrence H Schwartz
JAMA|January 28, 2015
MR/ultrasound fusion-guided biopsy in prostate cancer: what is the evidentiary standard?Lawrence H Schwartz, Ethan Basch
European Journal of Cancer (Oxford, England : 1990)|December 7, 2007
How to assess anti-tumour efficacy by imaging techniquesStephen J Gwyther, Lawrence H Schwartz
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncologySteven M Larson, Lawrence H Schwartz
Cancer|January 29, 2010
Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survivalGeoffrey R Oxnard, Lawrence H Schwartz
The Journal of Bone and Joint Surgery. American Volume|April 4, 2003
Shoulder impingement presenting as neck painJerrold M Gorski, Lawrence H Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Response phenotype as a predictive biomarker to guide treatment with targeted therapiesGeoffrey R Oxnard, Lawrence H Schwartz
Seminars in Musculoskeletal Radiology|March 28, 2002
MR imaging after surgery for musculoskeletal neoplasmDavid M Panicek, Lawrence H Schwartz
Aging|November 19, 2023
Artificial intelligence for aging research in cancer drug developmentDorsa Shirini, Lawrence H Schwartz, Laurent Dercle
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2020
iRECIST: how to do itThorsten Persigehl, Simon Lennartz, Lawrence H Schwartz
Pageof 28

Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
The Oncologist|October 1, 2009
Contemporary imaging in sarcomaJonathan Landa, Lawrence H Schwartz
JAMA|January 28, 2015
MR/ultrasound fusion-guided biopsy in prostate cancer: what is the evidentiary standard?Lawrence H Schwartz, Ethan Basch
European Journal of Cancer (Oxford, England : 1990)|December 7, 2007
How to assess anti-tumour efficacy by imaging techniquesStephen J Gwyther, Lawrence H Schwartz
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncologySteven M Larson, Lawrence H Schwartz
Cancer|January 29, 2010
Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survivalGeoffrey R Oxnard, Lawrence H Schwartz
The Journal of Bone and Joint Surgery. American Volume|April 4, 2003
Shoulder impingement presenting as neck painJerrold M Gorski, Lawrence H Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Response phenotype as a predictive biomarker to guide treatment with targeted therapiesGeoffrey R Oxnard, Lawrence H Schwartz
Seminars in Musculoskeletal Radiology|March 28, 2002
MR imaging after surgery for musculoskeletal neoplasmDavid M Panicek, Lawrence H Schwartz
Aging|November 19, 2023
Artificial intelligence for aging research in cancer drug developmentDorsa Shirini, Lawrence H Schwartz, Laurent Dercle
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 5, 2020
iRECIST: how to do itThorsten Persigehl, Simon Lennartz, Lawrence H Schwartz
Pageof 28